Hims & Hers Health, Inc. (HIMS) Financial Statements (2025 and earlier)

Company Profile

Business Address 2269 CHESTNUT ST
SAN FRANCISCO, CA 94123
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8011 - Offices and Clinics of Doctors of Medicine (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments322,671300,251254,071227,292203,592220,981
Cash and cash equivalent273,736220,584165,518129,295105,23796,663
Short-term investments48,93579,66788,55397,99798,355124,318
Receivables  6,100   6,700
Inventory, net of allowances, customer advances and progress billings76,09664,42749,11040,58829,82622,464
Inventory76,09664,42749,11040,58829,82622,464
Prepaid expense29,08316,17212,90014,19415,07910,665
Other current assets12,1708,9015,7203,2936,8325,238
Other undisclosed current assets6,944(20)4,5745,5516,405(995)
Total current assets:446,964395,831326,375290,918261,734265,053
Noncurrent Assets
Operating lease, right-of-use asset62,19810,88110,88411,03411,4229,588
Property, plant and equipment(29,659)(24,499)(19,921)(17,147)(14,244)(12,244)
Intangible assets, net (including goodwill)161,184156,138157,546128,014128,744129,455
Goodwill117,753112,728112,728110,881110,881110,881
Intangible assets, net (excluding goodwill)43,43143,41044,81817,13317,86318,574
Restricted cash and investments1,223856856856856856
Deferred income tax assets62,49361,60354,318   
Other noncurrent assets1,94214713813813891
Other undisclosed noncurrent assets185,366106,58272,06566,68759,45648,387
Total noncurrent assets:444,747311,708275,886189,582186,372176,133
TOTAL ASSETS:891,711707,539602,261480,500448,106441,186
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities165,861144,193118,66886,04770,63372,042
Accounts payable108,91991,18075,44457,09943,91943,070
Accrued liabilities56,94253,01343,22428,94826,71428,972
Deferred revenue110,76575,28532,18420,99013,7357,733
Business combination, contingent consideration, liability     7,4127,412
Other undisclosed current liabilities3,7361,8891,7931,6341,5441,281
Total current liabilities:280,362221,367152,645108,67193,32488,468
Noncurrent Liabilities
Long-term debt and lease obligation      
Long-term debt, excluding current maturities      
Liabilities, other than long-term debt62,0889,4569,5659,86310,3008,689
Other liabilities2,440  222122
Operating lease, liability59,6489,4569,5659,84110,2798,667
Total noncurrent liabilities:62,0889,4569,5659,86310,3008,689
Total liabilities:342,450230,823162,210118,534103,62497,157
Equity
Equity, attributable to parent549,261476,716440,051361,966344,482344,029
Common stock222222222121
Additional paid in capital742,055719,155707,962705,862701,670712,307
Accumulated other comprehensive income (loss)(164)(324)229(168)(162)(124)
Accumulated deficit(192,652)(242,137)(268,162)(343,750)(357,047)(368,175)
Total equity:549,261476,716440,051361,966344,482344,029
TOTAL LIABILITIES AND EQUITY:891,711707,539602,261480,500448,106441,186

Income Statement (P&L) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Revenues586,010481,139401,556315,648278,171246,619
Cost of revenue(155,321)(111,598)(83,670)(59,035)(49,076)(42,561)
Gross profit:430,689369,541317,886256,613229,095204,058
Operating expenses(372,792)(350,945)(295,512)(245,583)(219,192)(204,458)
Operating income (loss):57,89718,59622,37411,0309,903(400)
Nonoperating income2,5983,6951,2192,3942,5002,596
Other nonoperating income  3,6951,2192,3942,5002,615
Income from continuing operations before income taxes:60,49522,29123,59313,42412,4032,196
Income tax expense (benefit)(11,010)3,73451,995(127)(1,275)(951)
Net income available to common stockholders, diluted:49,48526,02575,58813,29711,1281,245

Comprehensive Income ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Net income:49,48526,02575,58813,29711,1281,245
Comprehensive income:49,48526,02575,58813,29711,1281,245
Other undisclosed comprehensive income (loss), net of tax, attributable to parent160(553)397(6)(38)9
Comprehensive income, net of tax, attributable to parent:49,64525,47275,98513,29111,0901,254

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: